Latest On Zai Lab Limited (ZLAB):
About Zai Lab Limited (ZLAB):
Zai Lab Limited, a biopharmaceutical company, discovers, licenses, develops, and commercializes therapeutics to treat oncology, autoimmune, and infectious diseases in China. The company offers ZEJULA for the treatment of breast cancer and non-small cell lung cancer (NSCLC); and Optune, a cancer therapy to treat glioblastoma multiforme. It also develops QINLOCK for the treatment of gastrointestinal stromal tumors; Odronextamab to treat follicular lymphoma, diffuse large B-cell lymphoma, and other lymphomas; Repotrectinib, a tyrosine kinase inhibitor (TKI) to target ROS1 and TRK A/B/C in TKI-naïve- or -pretreated cancer patients; Margetuximab for the treatment of breast and gastroesophageal cancers; Bemarituzumab for the treatment of gastric and gastroesophageal junction cancer; and Omadacycline to treat acute bacterial skin and skin structure, and community-acquired bacterial pneumonia infections. In addition, the company develops CLN-081 for the treatment of patients with EGFR exon 20 insertion NSCLC; Efgartigimod to reduce disease-causing immunoglobulin G (IgG) antibodies; Retifanlimab to treat microsatellite instability high endometrial cancer; ZL-2309 for the treatment of metastatic pancreatic cancer, metastatic colorectal cancer, and other advanced solid tumors; ZL-1201 to treat solid tumors and hematological malignancies; ZL-1102 for the treatment of psoriasis; and Sulbactam/durlobactam for the treatment of serious infections caused by Acinetobacter. Zai Lab Limited has license and collaboration agreements with the GlaxoSmithKline; Paratek Bermuda, Ltd.; Five Prime Therapeutics, Inc.; Entasis Therapeutics Holdings, Inc.; Crescendo Biologics Ltd.; Novocure Limited; MacroGenics Inc.; Deciphera Pharmaceuticals, LLC; Incyte Corporation; Regeneron Ireland Designated Activity Company; Turning Point Therapeutics Inc; Cullinan Pearl Corp.; Takeda Pharmaceutical Company Limited; and argenx BV. The company was incorporated in 2013 and is headquartered in Shanghai, China.
General
- Name Zai Lab Limited
- Symbol ZLAB
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 1,194
- Fiscal Year EndDecember
- IPO Date2017-09-20
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.zailaboratory.com
Valuation
- Price/Sales (Trailing 12 Mt.) 227.95
- Price/Book (Most Recent Quarter) 10.89
- Enterprise Value Revenue 239.45
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$3.50
- Next Year EPS Estimate -$2.31
- Next Quarter EPS Estimate -$0.86
- Operating Margin -616%
- Return on Assets -23%
- Return on Equity -37%
- Revenue 48.96 million
- Earnings Per Share -$3.12
- Revenue Per Share $0.63
- Gross Profit 32.22 million
- Quarterly Earnings Growth 220.2%
Highlights
- Market Capitalization 11.91 billion
- EBITDA -184450048
- Analyst Target Price $174.24
- Book Value Per Share $13.32
Share Statistics
- Shares Outstanding 88.02 million
- Shares Float 70.76 million
- % Held by Insiders 118%
- % Held by Institutions 70.22%
- Shares Short 1.46 million
- Shares Short Prior Month 1.63 million
- Short Ratio 3.79
- Short % of Shares Outstanding 2%
Technicals
- Beta 1.14
- 52 Week High $193.54
- 52 Week Low $44.77
- 50 Day Moving Average 159.3
- 200 Day Moving Average 119.56
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
Zai Lab Limited (ZLAB) Dividend Calendar:
Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
---|
Zai Lab Limited (ZLAB) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
---|---|---|---|---|---|
2019-12-31 | 2020-03-19 | $4.65 million | -$0.68 | -$0.60 | -14.23% |
2019-09-30 | 2019-11-27 | $4.92 million | -$1.03 | -$0.63 | -63.49% |
Zai Lab Limited (ZLAB) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
Date |
---|
Research Development |
Income Before Tax |
Selling General Administrative |
Gross Profit |
Ebit |
Operating Income |
Income Tax Expense |
Total Revenue |
Cost of Revenue |
Total Other Income Expense Net |
Net Income From Continuing Operations |
Net Income Applicable to Common Shares |
Cash Flow:
Date |
---|
Investments |
Change to Liabilities |
Total Cash Flow from Investing Activities |
Net Borrowings |
Total Cash Flow from Financial Activities |
Change to Operating Activities |
Change in Cash |
Total Cash from Operating Activities |
Depreciation |
Other Cash Flow from Investing Activities |
Change to Inventory |
Change to Account Receivables |
Other Cash Flow from Financing Activities |
Change to Net Income |
Capital Expenditures |
Balance Sheet:
Date |
---|
Total Liabailities |
Total Stockholder Equity |
Other Current Liabilities |
Total Assets |
Common Stock |
Other Current Assets |
Retained Earnings |
Other Liabilities |
Other Assets |
Cash |
Total Current Liabilities |
Other Stockholder Equity |
Property, Plant & Equipment |
Total Current Assets |
Long Term Investments |
Net Tangible Assets |
Short Term Investments |
Long Term Debt |
Inventory |
Accounts Payable |
Zai Lab Limited (ZLAB) Chart:
Zai Lab Limited (ZLAB) News:
Below you will find a list of latest news for Zai Lab Limited (ZLAB) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Zai Lab Limited (ZLAB) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
---|---|---|---|---|---|---|---|---|---|
2024-05-17 | 2.5 | 0 | CALL | 0 | 0 | 1329.35 | TRUE | 0 | 0 |
2024-05-17 | 5 | 0 | CALL | 0 | 0 | 423.38 | TRUE | 0 | 0 |
2024-05-17 | 7.5 | 0 | CALL | 0 | 0 | 192.58 | TRUE | 0 | 0 |
2024-05-17 | 10 | 0 | CALL | 0 | 0 | 186.2 | TRUE | 0 | 0 |
2024-05-17 | 12.5 | 0 | CALL | 0 | 0 | 119.01 | TRUE | 0 | 0 |
2024-05-17 | 15 | 1.33 | CALL | 2 | 195 | 85.64 | FALSE | 0.48 | 0.56 |
2024-05-17 | 17.5 | 0.45 | CALL | 13 | 38 | 80.55 | FALSE | 0.3 | 2 |
2024-05-17 | 20 | 0.33 | CALL | 0 | 24 | 82.48 | FALSE | 0 | 0 |
2024-05-17 | 22.5 | 1.15 | CALL | 0 | 1 | 0 | FALSE | 0 | 0 |
2024-05-17 | 25 | 0.09 | CALL | 0 | 1 | 0 | FALSE | 0 | 0 |
2024-05-17 | 30 | 0.05 | CALL | 0 | 1 | 0 | FALSE | 0 | 0 |
2024-05-17 | 35 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-05-17 | 40 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-05-17 | 2.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-05-17 | 5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-05-17 | 7.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-05-17 | 10 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-05-17 | 12.5 | 0.75 | PUT | 0 | 54 | 117.47 | FALSE | 0 | 0 |
2024-05-17 | 15 | 1.15 | PUT | 1 | 122 | 76.36 | TRUE | -0.6 | -0.34 |
2024-05-17 | 17.5 | 0 | PUT | 0 | 0 | 133.84 | TRUE | 0 | 0 |
2024-05-17 | 20 | 0 | PUT | 0 | 0 | 123.44 | TRUE | 0 | 0 |
2024-05-17 | 22.5 | 0 | PUT | 0 | 0 | 173.72 | TRUE | 0 | 0 |
2024-05-17 | 25 | 6.44 | PUT | 0 | 0 | 175.53 | TRUE | 0 | 0 |
2024-05-17 | 30 | 0 | PUT | 0 | 0 | 247.83 | TRUE | 0 | 0 |
2024-05-17 | 35 | 0 | PUT | 0 | 0 | 212.15 | TRUE | 0 | 0 |
2024-05-17 | 40 | 0 | PUT | 0 | 0 | 244.08 | TRUE | 0 | 0 |
2024-06-21 | 2.5 | 0 | CALL | 0 | 0 | 847.05 | TRUE | 0 | 0 |
2024-06-21 | 5 | 0 | CALL | 0 | 0 | 221.04 | TRUE | 0 | 0 |
2024-06-21 | 7.5 | 0 | CALL | 0 | 0 | 116.64 | TRUE | 0 | 0 |
2024-06-21 | 10 | 7.3 | CALL | 0 | 1 | 127.06 | TRUE | 0 | 0 |
2024-06-21 | 12.5 | 0 | CALL | 0 | 0 | 99.08 | TRUE | 0 | 0 |
2024-06-21 | 15 | 12.68 | CALL | 0 | 1 | 77.07 | FALSE | 0 | 0 |
2024-06-21 | 17.5 | 1 | CALL | 1 | 77 | 75.87 | FALSE | 1 | 0 |
2024-06-21 | 20 | 0.63 | CALL | 0 | 184 | 69.58 | FALSE | 0 | 0 |
2024-06-21 | 22.5 | 0.35 | CALL | 0 | 231 | 81.52 | FALSE | 0 | 0 |
2024-06-21 | 25 | 0.6 | CALL | 0 | 133 | 0 | FALSE | 0 | 0 |
2024-06-21 | 30 | 0.15 | CALL | 1 | 9 | 99.79 | FALSE | 0.15 | 0 |
2024-06-21 | 35 | 0.05 | CALL | 0 | 333 | 0 | FALSE | 0 | 0 |
2024-06-21 | 40 | 0.05 | CALL | 0 | 62 | 0 | FALSE | 0 | 0 |
2024-06-21 | 45 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-06-21 | 50 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-06-21 | 2.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-06-21 | 5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-06-21 | 7.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-06-21 | 10 | 0 | PUT | 0 | 0 | 111.89 | FALSE | 0 | 0 |
2024-06-21 | 12.5 | 1.3 | PUT | 0 | 49 | 90.96 | FALSE | 0 | 0 |
2024-06-21 | 15 | 1.95 | PUT | 0 | 8 | 78.63 | TRUE | 0 | 0 |
2024-06-21 | 17.5 | 3.6 | PUT | 0 | 13 | 70.08 | TRUE | 0 | 0 |
2024-06-21 | 20 | 6.23 | PUT | 0 | 18 | 82.12 | TRUE | 0 | 0 |
2024-06-21 | 22.5 | 7.2 | PUT | 0 | 22 | 84.78 | TRUE | 0 | 0 |
2024-06-21 | 25 | 9.4 | PUT | 0 | 103 | 95.4 | TRUE | 0 | 0 |
2024-06-21 | 30 | 6.3 | PUT | 0 | 0 | 123.79 | TRUE | 0 | 0 |
2024-06-21 | 35 | 9.2 | PUT | 0 | 0 | 159.57 | TRUE | 0 | 0 |
2024-06-21 | 40 | 0 | PUT | 0 | 0 | 208.54 | TRUE | 0 | 0 |
2024-06-21 | 45 | 0 | PUT | 0 | 0 | 174.3 | TRUE | 0 | 0 |
2024-06-21 | 50 | 0 | PUT | 0 | 0 | 186.98 | TRUE | 0 | 0 |
2024-09-20 | 2.5 | 0 | CALL | 0 | 0 | 213.57 | TRUE | 0 | 0 |
2024-09-20 | 5 | 0 | CALL | 0 | 0 | 90.56 | TRUE | 0 | 0 |
2024-09-20 | 7.5 | 0 | CALL | 0 | 0 | 104.36 | TRUE | 0 | 0 |
2024-09-20 | 10 | 0 | CALL | 0 | 0 | 91.28 | TRUE | 0 | 0 |
2024-09-20 | 12.5 | 3.7 | CALL | 0 | 29 | 62.05 | TRUE | 0 | 0 |
2024-09-20 | 15 | 0 | CALL | 0 | 0 | 52.59 | FALSE | 0 | 0 |
2024-09-20 | 17.5 | 3.4 | CALL | 0 | 2 | 71.07 | FALSE | 0 | 0 |
2024-09-20 | 20 | 1.95 | CALL | 0 | 20 | 81.79 | FALSE | 0 | 0 |
2024-09-20 | 22.5 | 0.9 | CALL | 0 | 20 | 70.81 | FALSE | 0 | 0 |
2024-09-20 | 25 | 0.7 | CALL | 0 | 67 | 69.37 | FALSE | 0 | 0 |
2024-09-20 | 30 | 0 | CALL | 0 | 0 | 90.54 | FALSE | 0 | 0 |
2024-09-20 | 35 | 0.85 | CALL | 0 | 30 | 84.12 | FALSE | 0 | 0 |
2024-09-20 | 2.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-09-20 | 5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-09-20 | 7.5 | 0 | PUT | 0 | 0 | 136.93 | FALSE | 0 | 0 |
2024-09-20 | 10 | 0 | PUT | 0 | 0 | 72.91 | FALSE | 0 | 0 |
2024-09-20 | 12.5 | 1.5 | PUT | 6 | 3 | 76.92 | FALSE | -0.1 | -0.06 |
2024-09-20 | 15 | 2.55 | PUT | 0 | 15 | 64.45 | TRUE | 0 | 0 |
2024-09-20 | 17.5 | 4.8 | PUT | 0 | 4 | 68.94 | TRUE | 0 | 0 |
2024-09-20 | 20 | 5.31 | PUT | 0 | 9 | 71.16 | TRUE | 0 | 0 |
2024-09-20 | 22.5 | 3.7 | PUT | 0 | 8 | 89.03 | TRUE | 0 | 0 |
2024-09-20 | 25 | 8.4 | PUT | 0 | 1 | 95.96 | TRUE | 0 | 0 |
2024-09-20 | 30 | 11.1 | PUT | 0 | 3 | 90.62 | TRUE | 0 | 0 |
2024-09-20 | 35 | 0 | PUT | 0 | 0 | 120.6 | TRUE | 0 | 0 |
2024-12-20 | 2.5 | 0 | CALL | 0 | 0 | 417.13 | TRUE | 0 | 0 |
2024-12-20 | 5 | 15 | CALL | 0 | 1 | 136.62 | TRUE | 0 | 0 |
2024-12-20 | 7.5 | 0 | CALL | 0 | 0 | 108.61 | TRUE | 0 | 0 |
2024-12-20 | 10 | 9.74 | CALL | 0 | 5 | 67.09 | TRUE | 0 | 0 |
2024-12-20 | 12.5 | 6.3 | CALL | 0 | 13 | 72.48 | TRUE | 0 | 0 |
2024-12-20 | 15 | 0 | CALL | 0 | 0 | 69.74 | FALSE | 0 | 0 |
2024-12-20 | 17.5 | 3.45 | CALL | 0 | 12 | 65.46 | FALSE | 0 | 0 |
2024-12-20 | 20 | 2.39 | CALL | 0 | 17 | 69.61 | FALSE | 0 | 0 |
2024-12-20 | 22.5 | 1.34 | CALL | 0 | 11 | 70.98 | FALSE | 0 | 0 |
2024-12-20 | 25 | 1.85 | CALL | 0 | 46 | 69.66 | FALSE | 0 | 0 |
2024-12-20 | 30 | 0.74 | CALL | 0 | 25 | 85.32 | FALSE | 0 | 0 |
2024-12-20 | 35 | 0.76 | CALL | 0 | 50 | 81.11 | FALSE | 0 | 0 |
2024-12-20 | 40 | 0.9 | CALL | 0 | 8 | 0 | FALSE | 0 | 0 |
2024-12-20 | 45 | 1.55 | CALL | 0 | 14 | 88.94 | FALSE | 0 | 0 |
2024-12-20 | 50 | 0.4 | CALL | 1 | 9 | 88.34 | FALSE | 0.4 | 0 |
2024-12-20 | 2.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-12-20 | 5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
2024-12-20 | 7.5 | 0.55 | PUT | 0 | 1 | 96.49 | FALSE | 0 | 0 |
2024-12-20 | 10 | 0 | PUT | 0 | 0 | 76.04 | FALSE | 0 | 0 |
2024-12-20 | 12.5 | 0.8 | PUT | 0 | 2 | 71.15 | FALSE | 0 | 0 |
2024-12-20 | 15 | 2.9 | PUT | 38 | 43 | 65.6 | TRUE | 2.9 | 0 |
2024-12-20 | 17.5 | 4.9 | PUT | 0 | 676 | 67.14 | TRUE | 0 | 0 |
2024-12-20 | 20 | 6 | PUT | 0 | 2926 | 69.96 | TRUE | 0 | 0 |
2024-12-20 | 22.5 | 5 | PUT | 0 | 32 | 79.21 | TRUE | 0 | 0 |
2024-12-20 | 25 | 8.6 | PUT | 0 | 49 | 69.39 | TRUE | 0 | 0 |
2024-12-20 | 30 | 9 | PUT | 0 | 443 | 74.62 | TRUE | 0 | 0 |
2024-12-20 | 35 | 15.2 | PUT | 0 | 727 | 82.17 | TRUE | 0 | 0 |
2024-12-20 | 40 | 16.3 | PUT | 0 | 0 | 107.98 | TRUE | 0 | 0 |
2024-12-20 | 45 | 0 | PUT | 0 | 0 | 124.04 | TRUE | 0 | 0 |
2024-12-20 | 50 | 0 | PUT | 0 | 0 | 118.11 | TRUE | 0 | 0 |
2025-01-17 | 2.5 | 0 | CALL | 0 | 0 | 89.66 | TRUE | 0 | 0 |
2025-01-17 | 5 | 0 | CALL | 0 | 0 | 80.27 | TRUE | 0 | 0 |
2025-01-17 | 7.5 | 10.8 | CALL | 0 | 1 | 90.61 | TRUE | 0 | 0 |
2025-01-17 | 10 | 0 | CALL | 0 | 0 | 71.07 | TRUE | 0 | 0 |
2025-01-17 | 12.5 | 4.4 | CALL | 0 | 2 | 75.26 | TRUE | 0 | 0 |
2025-01-17 | 15 | 3.3 | CALL | 0 | 1 | 63.95 | FALSE | 0 | 0 |
2025-01-17 | 17.5 | 2.9 | CALL | 0 | 23 | 69.84 | FALSE | 0 | 0 |
2025-01-17 | 20 | 1.9 | CALL | 0 | 21 | 67.49 | FALSE | 0 | 0 |
2025-01-17 | 22.5 | 1.65 | CALL | 0 | 55 | 68.92 | FALSE | 0 | 0 |
2025-01-17 | 25 | 1.1 | CALL | 0 | 69 | 74.94 | FALSE | 0 | 0 |
2025-01-17 | 30 | 0.9 | CALL | 0 | 3 | 73.2 | FALSE | 0 | 0 |
2025-01-17 | 35 | 0.9 | CALL | 0 | 39 | 118.59 | FALSE | 0 | 0 |
2025-01-17 | 40 | 0 | CALL | 0 | 0 | 89.95 | FALSE | 0 | 0 |
2025-01-17 | 2.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
2025-01-17 | 5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
2025-01-17 | 7.5 | 0 | PUT | 0 | 0 | 86.97 | FALSE | 0 | 0 |
2025-01-17 | 10 | 1.2 | PUT | 0 | 5 | 85.82 | FALSE | 0 | 0 |
2025-01-17 | 12.5 | 1.9 | PUT | 110 | 71 | 69.02 | FALSE | 1.9 | 0 |
2025-01-17 | 15 | 3.2 | PUT | 0 | 305 | 65.74 | TRUE | 0 | 0 |
2025-01-17 | 17.5 | 4.4 | PUT | 0 | 15 | 70.14 | TRUE | 0 | 0 |
2025-01-17 | 20 | 0 | PUT | 0 | 0 | 72.05 | TRUE | 0 | 0 |
2025-01-17 | 22.5 | 9 | PUT | 0 | 2 | 75.92 | TRUE | 0 | 0 |
2025-01-17 | 25 | 0 | PUT | 0 | 0 | 85.07 | TRUE | 0 | 0 |
2025-01-17 | 30 | 0 | PUT | 0 | 0 | 87.47 | TRUE | 0 | 0 |
2025-01-17 | 35 | 0 | PUT | 0 | 0 | 86.55 | TRUE | 0 | 0 |
2025-01-17 | 40 | 0 | PUT | 0 | 0 | 94.52 | TRUE | 0 | 0 |
Latest ZLAB Trades:
Date | Shares | Price |
---|---|---|
Jun 13, 2022 7:59 PM EST | 27 | $25.23 |
Jun 13, 2022 7:59 PM EST | 100 | $25.23 |
Jun 13, 2022 7:59 PM EST | 49 | $25.18 |
Jun 13, 2022 7:59 PM EST | 6 | $25.18 |
Jun 13, 2022 7:59 PM EST | 100 | $25.18 |
Zai Lab Limited (ZLAB) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
Date | Form Type | Form Name | Link |
---|---|---|---|
2020-06-17 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1704292/000156459020029580/0001564590-20-029580-index.htm |
2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1704292/000031506619000812/0000315066-19-000812-index.htm |
2020-02-07 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1704292/000031506620001289/0000315066-20-001289-index.htm |
2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1704292/000090445419000247/0000904454-19-000247-index.htm |
2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1704292/000090445420000196/0000904454-20-000196-index.htm |
2020-08-10 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1704292/000090445420000552/0000904454-20-000552-index.htm |
2019-05-10 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1704292/000092963819000531/0000929638-19-000531-index.htm |
2020-02-03 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1704292/000092963820000139/0000929638-20-000139-index.htm |
2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1704292/000095010319001958/0000950103-19-001958-index.htm |
2019-03-29 | F-3ASR | Automatic shelf registration statement of securities of well-known seasoned issuers | https://www.sec.gov/Archives/edgar/data/1704292/000095010319004111/0000950103-19-004111-index.htm |
2019-05-01 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1704292/000095010319005677/0000950103-19-005677-index.htm |
2019-05-01 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1704292/000095010319005712/0000950103-19-005712-index.htm |
2019-05-01 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1704292/000095010319005714/0000950103-19-005714-index.htm |
2019-05-02 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1704292/000095010319005786/0000950103-19-005786-index.htm |
2019-05-03 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1704292/000095010319005917/0000950103-19-005917-index.htm |
2019-05-06 | 424B2 | Prospectus [Rule 424(b)(2)] | https://www.sec.gov/Archives/edgar/data/1704292/000095010319005999/0000950103-19-005999-index.htm |
2020-01-27 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1704292/000095010320001096/0000950103-20-001096-index.htm |
2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1704292/000095010320002781/0000950103-20-002781-index.htm |
2020-09-16 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1704292/000104746920004887/0001047469-20-004887-index.htm |
2020-09-23 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1704292/000104746920004959/0001047469-20-004959-index.htm |
2020-02-11 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1704292/000110465920015242/0001104659-20-015242-index.htm |
2020-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1704292/000110465920019426/0001104659-20-019426-index.htm |
2020-09-11 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1704292/000110465920104213/0001104659-20-104213-index.htm |
2020-09-11 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1704292/000110465920104219/0001104659-20-104219-index.htm |
2020-09-16 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1704292/000110465920105468/0001104659-20-105468-index.htm |
2020-09-21 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1704292/000110465920106975/0001104659-20-106975-index.htm |
2020-09-22 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1704292/000110465920107187/0001104659-20-107187-index.htm |
2020-09-28 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1704292/000110465920109116/0001104659-20-109116-index.htm |
2020-10-09 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1704292/000110465920113699/0001104659-20-113699-index.htm |
2020-10-22 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1704292/000110465920116998/0001104659-20-116998-index.htm |
2019-03-22 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1704292/000114420419015587/0001144204-19-015587-index.htm |
2020-01-21 | POSASR | Post-effective Amendment to an automatic shelf registration statement | https://www.sec.gov/Archives/edgar/data/1704292/000119312520011149/0001193125-20-011149-index.htm |
2020-01-21 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1704292/000119312520011154/0001193125-20-011154-index.htm |
2020-01-21 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1704292/000119312520011159/0001193125-20-011159-index.htm |
2020-01-22 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1704292/000119312520011793/0001193125-20-011793-index.htm |
2020-01-23 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1704292/000119312520012405/0001193125-20-012405-index.htm |
2020-01-24 | 424B2 | Prospectus [Rule 424(b)(2)] | https://www.sec.gov/Archives/edgar/data/1704292/000119312520013551/0001193125-20-013551-index.htm |
2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1704292/000119312520037636/0001193125-20-037636-index.htm |
2018-10-12 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1704292/000156459018024170/0001564590-18-024170-index.htm |
2018-10-22 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1704292/000156459018024568/0001564590-18-024568-index.htm |
2018-11-30 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1704292/000156459018030310/0001564590-18-030310-index.htm |
2018-12-12 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1704292/000156459018030832/0001564590-18-030832-index.htm |
2019-03-07 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1704292/000156459019006625/0001564590-19-006625-index.htm |
2019-03-29 | 20-F | Annual and transition report of foreign private issuers [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1704292/000156459019010185/0001564590-19-010185-index.htm |
2019-06-03 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1704292/000156459019021366/0001564590-19-021366-index.htm |
2019-06-11 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1704292/000156459019022165/0001564590-19-022165-index.htm |
2019-06-26 | 20-F/A | Annual and transition report of foreign private issuers [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1704292/000156459019023549/0001564590-19-023549-index.htm |
2019-07-02 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1704292/000156459019024284/0001564590-19-024284-index.htm |
2019-08-23 | 20-F/A | Annual and transition report of foreign private issuers [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1704292/000156459019032910/0001564590-19-032910-index.htm |
2019-09-03 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1704292/000156459019033837/0001564590-19-033837-index.htm |
2019-12-27 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1704292/000156459019046994/0001564590-19-046994-index.htm |
2020-01-14 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1704292/000156459020001004/0001564590-20-001004-index.htm |
2020-01-21 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1704292/000156459020001532/0001564590-20-001532-index.htm |
2020-03-16 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1704292/000156459020010986/0001564590-20-010986-index.htm |
2020-03-19 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1704292/000156459020011704/0001564590-20-011704-index.htm |
2020-04-08 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1704292/000156459020015797/0001564590-20-015797-index.htm |
2020-04-29 | 20-F | Annual and transition report of foreign private issuers [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1704292/000156459020019745/0001564590-20-019745-index.htm |
2020-05-13 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1704292/000156459020024889/0001564590-20-024889-index.htm |
2020-06-17 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1704292/000156459020029580/0001564590-20-029580-index.htm |
2020-07-07 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1704292/000156459020031884/0001564590-20-031884-index.htm |
2020-07-20 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1704292/000156459020032675/0001564590-20-032675-index.htm |
2020-08-13 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1704292/000156459020039799/0001564590-20-039799-index.htm |
2020-08-17 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1704292/000156459020040369/0001564590-20-040369-index.htm |
2020-09-04 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1704292/000156459020042650/0001564590-20-042650-index.htm |
2020-09-10 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1704292/000156459020043044/0001564590-20-043044-index.htm |
2020-09-18 | 20-F/A | Annual and transition report of foreign private issuers [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1704292/000156459020043994/0001564590-20-043994-index.htm |
2019-09-12 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1704292/999999999719006805/9999999997-19-006805-index.htm |